New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
08:21 EDTWAT, PACB, AFFX, SQNM, FLDM, PKI, DDXSMaxim recommends life science tools, diagnostics ahead of earnings
Maxim expects 2014 to be a "great year" for life science tools and diagnostics stocks and recommends buying Affymetrix (AFFX), diaDexus (DDXS), Fluidigm (FLDM), Pacific Biosciences (PACB), PerkinElmer (PKI), Sequenom (SQNM) and Waters (WAT) ahead of the Q4 results. Maxim has a preference for Pacific Biosciences, PerkinElmer and Waters. The firm raised its price target for Fluidigm to $52 from $42 and for Pacific Biosciences to $9 from $8.
News For AFFX;DDXS;FLDM;PACB;PKI;SQNM;WAT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
16:58 EDTPKIPerkinElmer sees FY15 adjusted EPS $2.55-$2.60, consensus $2.59
Subscribe for More Information
16:57 EDTPKIPerkinElmer reports Q2 adjusted EPS 60c, consensus 59c
Subscribe for More Information
15:04 EDTPKINotable companies reporting after market close
Subscribe for More Information
July 29, 2015
16:02 EDTAFFXAffymetrix backs FY15 revenue growth in mid-single digits, consensus $361.43M
Raises FY15 adjusted EBITDA to 17%-19% from 16%-18%.
16:01 EDTAFFXAffymetrix reports Q2 adjusted EPS 12c, consensus 7c
Subscribe for More Information
10:00 EDTWATOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: 3D Systems (DDD) upgraded to Neutral from Underperform at Longbow... AK Steel (AKS) upgraded to Outperform from Neutral at Macquarie... Ally Financial (ALLY) upgraded to Outperform from Neutral at Credit Suisse... Amazon.com (AMZN) upgraded to Buy from Hold at Stifel... Arrow Electronics (ARW) upgraded to Buy from Underperform at CLSA... Beacon Roofing (BECN) upgraded to Buy from Neutral at CL King... Citrix (CTXS) upgraded to Outperform at Baird... Commvault (CVLT) upgraded to Buy from Hold at Jefferies... FireEye (FEYE) upgraded on positive checks, business mdoel changes at Oppenheimer... Hibbett Sports (HIBB) upgraded to Neutral from Underperform at Sterne Agee CRT... Integra LifeSciences (IART) upgraded to Outperform at Raymond James... M/A-COM (MTSI) upgraded to Buy from Hold at Needham... Norsk Hydro (NHYDY) upgraded to Neutral from Underperform at Exane BNP Paribas... NuVasive (NUVA) upgraded to Outperform from Market Perform at Northland... SM Energy (SM) upgraded to Outperform from Market Perform at Raymond James... Scorpio Bulkers (SALT) upgraded to Buy from Hold at Deutsche Bank... Sirius XM (SIRI) upgraded to Buy from Hold at Wunderlich... Sprouts Farmers Markets (SFM) upgraded to Neutral from Underperform at Longbow... Supervalu (SVU) upgraded to Equal Weight from Underweight at Morgan Stanley... Waters (WAT) upgraded to Outperform from Market Perform at Wells Fargo... Wells Fargo (WFC) upgraded to Buy from Neutral at Guggenheim... Williams-Sonoma (WSM) upgraded to Overweight from Neutral at JPMorgan... YRC Worldwide (YRCW) upgraded to Strong Buy at Raymond James.
07:30 EDTWATWaters upgraded to Outperform on biopharma strength at Wells Fargo
Wells Fargo upgraded Waters Corporation to Outperform from Market Perform saying the company posted core revenue growth well above the industry average for the fourth consecutive quarter. It believes Waters' strength in biopharma is sustainable and raised its price target range for shares to $140-$145 from $125-$130.
06:20 EDTWATWaters upgraded to Outperform from Market Perform at Wells Fargo
Subscribe for More Information
July 28, 2015
08:52 EDTWATWaters sees Q3 EPS $1.33-$1.43, consensus $1.37
Sees Q3 constant currency sales growth 7%. Currency is expected to reduce sales by about 7%.
08:52 EDTWATWaters raises FY15 EPS view to $5.75-$5.90 from $5.67-$5.87
Subscribe for More Information
08:44 EDTWATWaters sees FY performance 'better' than original expectations
Subscribe for More Information
07:04 EDTWATWaters reports Q2 adjusted EPS $1.32, consensus $1.27
Subscribe for More Information
July 23, 2015
09:25 EDTFLDMFluidigm discloses CEO had violated conflict of interest provision
Subscribe for More Information
July 20, 2015
06:32 EDTAFFXAffymetrix and Cytox announce strategic partnership
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use